Randomized Clinical Trial on Efficacy of Empagliflozin Versus Sitagliptin, In Addition to Metformin in Type 2 Diabetic Patients

Introduction Diabetes mellitus is a syndrome affecting more than 28.7 million people worldwide and its prevalence in Pakistan is reported to be about 11%. Management includes lifestyle changes and varied therapeutic regimens. Metformin (MET) alone and in combinations is considered as an important ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Mubashir, Muaz, Ahmed, Mazhar, Atique, Hassan, Wassan, Ahmed, Naqvi, Mehdi, Ullah, Muneeb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767666/
https://www.ncbi.nlm.nih.gov/pubmed/36561596
http://dx.doi.org/10.7759/cureus.31699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767666/
https://www.ncbi.nlm.nih.gov/pubmed/36561596
http://dx.doi.org/10.7759/cureus.31699

Ejemplares similares